We are a social impact-focused company, dedicated to the research and development of Digital Therapeutics. Working alongside world-renown researchers, clinicians and patient groups, we are developing the next generation of digital medicines for patients with a range of long term conditions. We are the first scientifically validated digital therapeutic for inflammatory conditions. We are committed to value-based collaborations with clinicians, patients and the industry to achieve better health outcomes. Our team comprises leading clinicians from globally recognised hospitals in the UK and patients and patient groups are the heart of what we do. Collaborative research, in-depth analysis and evidence-based decisions drive all of our work. We believe we are a part of a thriving ecosystem addressing the biggest challenges to public health.
Member count: 11-50